Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Purrucker, Jan
DO-IT, NCT06571149: Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake	Not yet recruiting	4	906	Europe, Canada, Japan, RoW	Tenecteplase or Alteplase	Insel Gruppe AG, University Hospital Bern	Ischemic Stroke	01/29	04/29
FASTEST, NCT03496883: Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial	Recruiting	3	860	Europe, Canada, Japan, US	Recombinant Activated Factor VII (rFVIIa), NovoSeven, NiaStase, Placebo	Joseph Broderick, MD, Novo Nordisk A/S, National Institute of Neurological Disorders and Stroke (NINDS)	Intracerebral Hemorrhage	01/28	01/28
ODEA-TIA, NCT04075500: Optimal Detection of Atrial Fibrillation in TIA	Recruiting	N/A	1434	Europe	24-h Holter monitoring, Prolonged cardiac monitoring 28-day ECG, Prolonged cardiac monitoring implantable cardiac device	Alfried Krupp Krankenhaus	Atrial Fibrillation, Transient Ischemic Attack	12/23	12/23